Medical Disclaimer

Last updated: June 19, 2026.

The information on this website is provided by Tryozi Group LLC for general educational purposes only. It is not medical advice and is not a substitute for the judgment of a licensed clinician who knows your individual health history.

• No clinician–patient relationship is created by viewing this website. A clinician–patient relationship is established only through the telehealth intake and evaluation conducted by licensed clinicians via our medical partner, OpenLoop Healthcare Partners, PC and affiliated medical groups.
• A prescription is never guaranteed. GLP-1 medication is prescribed only if a licensed clinician determines it is appropriate for you after reviewing your information.
• Compounded medications are not FDA-approved. Tryozi's compounded semaglutide and compounded tirzepatide offerings are preparations made by licensed U.S. pharmacies to a clinician's prescription. They are distinct from the brand-name Ozempic® and Zepbound® products also offered through Tryozi and have not been evaluated or approved by the FDA.
• Individual results vary. Any outcome figures shown reflect published clinical trials of branded medications and are not a promise of your results.
• Statements on this site have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.

GLP-1 medication is not right for everyone. Do not use it if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Tell your clinician about all of your conditions and medications, including if you are pregnant or breastfeeding.

In a medical emergency, call 911 or your local emergency number. Do not rely on this website for urgent medical needs.

Questions: Tryozi Group LLC, 21113 Johnson St, Ste 101, Pembroke Pines, FL 33029.